A
Aldo Bigotti
Researcher at Chiba University
Publications - 49
Citations - 3871
Aldo Bigotti is an academic researcher from Chiba University. The author has contributed to research in topics: Monoclonal antibody & Antigen. The author has an hindex of 32, co-authored 49 publications receiving 3821 citations. Previous affiliations of Aldo Bigotti include New York Medical College.
Papers
More filters
Journal ArticleDOI
A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.
Barbara Carnemolla,Enrica Balza,Annalisa Siri,Luciano Zardi,Maria Rita Nicotra,Aldo Bigotti,P. G. Natali +6 more
TL;DR: The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium, and the results demonstrate that, in vivo, different FN isoforms have a differential distribution.
Journal Article
Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
P. G. Natali,Maria Rita Nicotra,R. Cavaliere,Aldo Bigotti,Gaetano Romano,Massimo Temponi,Soldano Ferrone +6 more
TL;DR: Results suggest that ICAM-1 may be a useful marker in the analysis of the molecular mechanism underlying the association between lesion thickness and clinical course of the disease.
Journal ArticleDOI
Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.
Pier Giorgio Natali,Maria Rita Nicotra,Aldo Bigotti,Irene Venturo,Dennis J. Slamon,Brian M. Fendly,Axel Ullrich +6 more
TL;DR: The findings indicate that the expression of the p185 HER2 represents a tumor marker of clinical relevance in breast cancer, and whether this holds true for other malignancies remains to be explored.
Journal ArticleDOI
Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression
P. G. Natali,Maria Rita Nicotra,M. F. Di Renzo,Maria Prat,Aldo Bigotti,Renato Cavaliere,Paolo M. Comoglio +6 more
TL;DR: Findings show that the c-MET gene is expressed at late stages of melanoma progression and suggest that the presence of Met/HGF receptor may contribute to the acquisition of an invasive phenotype.
Journal Article
Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.
TL;DR: The present results demonstrate that the c-kit receptor plays a role in the development of a larger spectrum of cell lineages, and speculate that, while in some cell types, c-Kit expression positively regulates mitogenesis and is selected for in neoplastic transformation, in other tissues thec-kit pathway is involved in morphogenesis and differentiation and is, therefore, negatively selected in the course of tumor progression.